OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clozapine in bipolar disorder: A systematic review and meta-analysis
A. Delgado, J. Velosa, Junyu Zhang, et al.
Journal of Psychiatric Research (2020) Vol. 125, pp. 21-27
Closed Access | Times Cited: 48
A. Delgado, J. Velosa, Junyu Zhang, et al.
Journal of Psychiatric Research (2020) Vol. 125, pp. 21-27
Closed Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review
Elias Wagner, Spyridon Siafis, Piyumi Fernando, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 102
Elias Wagner, Spyridon Siafis, Piyumi Fernando, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 102
Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress–Induced Damage in Patients with Bipolar Disorder
Sahithi Madireddy, Samskruthi Madireddy
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1844-1844
Open Access | Times Cited: 42
Sahithi Madireddy, Samskruthi Madireddy
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1844-1844
Open Access | Times Cited: 42
Application of Antipsychotic Drugs in Mood Disorders
Janusz Rybakowski
Brain Sciences (2023) Vol. 13, Iss. 3, pp. 414-414
Open Access | Times Cited: 23
Janusz Rybakowski
Brain Sciences (2023) Vol. 13, Iss. 3, pp. 414-414
Open Access | Times Cited: 23
Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?
Dara Gammon, Catherine Cheng, Anna Volkovinskaia, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 1030-1030
Open Access | Times Cited: 51
Dara Gammon, Catherine Cheng, Anna Volkovinskaia, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 1030-1030
Open Access | Times Cited: 51
The Modernization of Clozapine
Jonathan G. Leung, José de León, Mark A. Frye, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 6, pp. 565-580
Closed Access | Times Cited: 30
Jonathan G. Leung, José de León, Mark A. Frye, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 6, pp. 565-580
Closed Access | Times Cited: 30
Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study
Markku Lähteenvuo, Tapio Paljärvi, Antti Tanskanen, et al.
The British Journal of Psychiatry (2023) Vol. 223, Iss. 4, pp. 456-464
Open Access | Times Cited: 19
Markku Lähteenvuo, Tapio Paljärvi, Antti Tanskanen, et al.
The British Journal of Psychiatry (2023) Vol. 223, Iss. 4, pp. 456-464
Open Access | Times Cited: 19
Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug
Liliana Dell’Osso, Chiara Bonelli, Benedetta Nardi, et al.
Brain Sciences (2024) Vol. 14, Iss. 1, pp. 103-103
Open Access | Times Cited: 7
Liliana Dell’Osso, Chiara Bonelli, Benedetta Nardi, et al.
Brain Sciences (2024) Vol. 14, Iss. 1, pp. 103-103
Open Access | Times Cited: 7
Mood Stabilizers of First and Second Generation
Janusz Rybakowski
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 741-741
Open Access | Times Cited: 15
Janusz Rybakowski
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 741-741
Open Access | Times Cited: 15
Constipation in hospitalized psychiatric patients: An underestimated common phenomenon. Retrospective epidemiological study in an adult psychiatric hospital setting
Valérie Dauriac‐Le Masson, Cédric Bornes, Lisa Hadjedj, et al.
L Encéphale (2024) Vol. 50, Iss. 5, pp. 549-556
Closed Access | Times Cited: 5
Valérie Dauriac‐Le Masson, Cédric Bornes, Lisa Hadjedj, et al.
L Encéphale (2024) Vol. 50, Iss. 5, pp. 549-556
Closed Access | Times Cited: 5
Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic Disorders
Mete Ercis, Kristin Cole, Ross Dierkhising, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Mete Ercis, Kristin Cole, Ross Dierkhising, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
The alteration of drug metabolism enzymes and pharmacokinetic parameters in nonalcoholic fatty liver disease: current animal models and clinical practice
Yan Zhu, Li Chen, Yuqi He, et al.
Drug Metabolism Reviews (2023) Vol. 55, Iss. 3, pp. 163-180
Open Access | Times Cited: 11
Yan Zhu, Li Chen, Yuqi He, et al.
Drug Metabolism Reviews (2023) Vol. 55, Iss. 3, pp. 163-180
Open Access | Times Cited: 11
Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders
Ronald Mlambo, Jia Liu, Qian Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 603-603
Open Access | Times Cited: 11
Ronald Mlambo, Jia Liu, Qian Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 603-603
Open Access | Times Cited: 11
A Working Hypothesis Regarding Identical Pathomechanisms between Clinical Efficacy and Adverse Reaction of Clozapine via the Activation of Connexin43
Motohiro Okada, Kouji Fukuyama, Takashi Shiroyama, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7019-7019
Open Access | Times Cited: 31
Motohiro Okada, Kouji Fukuyama, Takashi Shiroyama, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7019-7019
Open Access | Times Cited: 31
Astroglial Connexin43 as a Potential Target for a Mood Stabiliser
Motohiro Okada, Tomoka Oka, Misaki Nakamoto, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 339-339
Open Access | Times Cited: 30
Motohiro Okada, Tomoka Oka, Misaki Nakamoto, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 339-339
Open Access | Times Cited: 30
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics
Marco Carli, Francesco Weiss, Giovanna Grenno, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 4, pp. 935-950
Open Access | Times Cited: 9
Marco Carli, Francesco Weiss, Giovanna Grenno, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 4, pp. 935-950
Open Access | Times Cited: 9
Clozapine Treatment for Aggressive Behaviors in Youths with Neurodevelopmental Disorders
Stefano Berloffa, Gabriele Masi, Francesca Falcone, et al.
Journal of Child and Adolescent Psychopharmacology (2024) Vol. 34, Iss. 3, pp. 148-156
Closed Access | Times Cited: 3
Stefano Berloffa, Gabriele Masi, Francesca Falcone, et al.
Journal of Child and Adolescent Psychopharmacology (2024) Vol. 34, Iss. 3, pp. 148-156
Closed Access | Times Cited: 3
Overcoming clozapine’s adverse events: a narrative review of systematic reviews and meta-analyses
Timothy Tanzer, Betty Pham, Nicola Warren, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 7, pp. 811-831
Closed Access | Times Cited: 3
Timothy Tanzer, Betty Pham, Nicola Warren, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 7, pp. 811-831
Closed Access | Times Cited: 3
A Systematic Review of Clozapine Concentration–Dose Ratio from Therapeutic Drug Monitoring Studies in Children and Adolescents Treated with Clozapine for Mental Disorders
Sara Jiménez‐Fernández, Manuel Gurpegui, Christoph U. Correll, et al.
Therapeutic Drug Monitoring (2023)
Open Access | Times Cited: 8
Sara Jiménez‐Fernández, Manuel Gurpegui, Christoph U. Correll, et al.
Therapeutic Drug Monitoring (2023)
Open Access | Times Cited: 8
Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review
André Luiz Schuh Teixeira, Olivia Sorato Bezerra, Luís Augusto Rohde, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 4, pp. 324-343
Closed Access | Times Cited: 2
André Luiz Schuh Teixeira, Olivia Sorato Bezerra, Luís Augusto Rohde, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 4, pp. 324-343
Closed Access | Times Cited: 2
Neurophysiological profiles of patients with bipolar disorders as probed with transcranial magnetic stimulation: A systematic review
Keita Taniguchi, Naotsugu Kaneko, Masataka Wada, et al.
Neuropsychopharmacology Reports (2024) Vol. 44, Iss. 3, pp. 572-584
Open Access | Times Cited: 2
Keita Taniguchi, Naotsugu Kaneko, Masataka Wada, et al.
Neuropsychopharmacology Reports (2024) Vol. 44, Iss. 3, pp. 572-584
Open Access | Times Cited: 2
Advances in Mood Disorder Pharmacotherapy: Evaluating New Antipsychotics and Mood Stabilizers for Bipolar Disorder and Schizophrenia
Emilia Kowalczyk, Sylwia Koziej, Ewelina Soroka
Medical Science Monitor (2024) Vol. 30
Open Access | Times Cited: 1
Emilia Kowalczyk, Sylwia Koziej, Ewelina Soroka
Medical Science Monitor (2024) Vol. 30
Open Access | Times Cited: 1
Clozapine—serious adverse effects and clinical management
Vlad Dionisie
Elsevier eBooks (2024), pp. 329-355
Closed Access | Times Cited: 1
Vlad Dionisie
Elsevier eBooks (2024), pp. 329-355
Closed Access | Times Cited: 1
Effects of Sex Differences and Combined Use of Clozapine on Initial Dosage Optimization of Valproic Acid in Patients with Bipolar Disorder
Wei Shen, Ke Hu, Hao-Zhe Shi, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 29, pp. 2290-2302
Closed Access | Times Cited: 1
Wei Shen, Ke Hu, Hao-Zhe Shi, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 29, pp. 2290-2302
Closed Access | Times Cited: 1
